Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B—Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset —9 top biopharma CEO-to-employee pay gaps --http://bit.ly/w28kSd #biogen #mergersandacquisitions #boehringeringelheim #cardiovasculardisease #pharmaceos #executivecompensation #paygap #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal—In his final full year as AbbVie's CEO, Richard Gonzalez collects $25.7M in total pay—Bayer cues up filings for rival to Astellas’ menopause drug--http://bit.ly/w28kSd #astrazeneca #mergersandacquisitions #radiopharmaceuticals #pharmaceos #executivecompensation #abbvie #bayer #hotflashes #menopause #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss-- 5 of the best paid biopharma CEOs --One dose of Lilly’s siRNA drug cuts Lp(a) for a year -- See more on our front page news http://bit.ly/w28kSd #novonordisk #wegovy #heartdisease #clinicaltrials #executivepay #pharmaceos #ceos #aha #elililly #sirna #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches-- Bayer CEO Anderson says 'radical realignment' is underway --Gilead tumbles after unpredictable element drove its 3Q beat -- See more on our front page news http://bit.ly/w28kSd #biogen #pharmaceos #bayer #layoffs #gileadsciences #earnings #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations-- Sen. Bernie Sanders moves toward another hearing with pharma CEOs --Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March -- See more on our front page news http://bit.ly/w28kSd #vertexpharmaceuticals #genetherapy #senate #drugpricing #pharmaceos #berniesanders #eisai #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma